PRESS RELEASES

2017

December 19
Clinical Genomics Pathology Inc. Receives Accreditation from College of American Pathologists (CAP) for Liquid Biopsy Lab

December 12
Roy Davis joins liquid biopsy company Clinical Genomics board of directors

November 30
Clinical Genomics receives CSIRO award for Entrepreneurship in Science

November 28
Clinical Genomics appoints Roger Moody as Chief Financial Officer

November 13
Clinical Genomics and Quest Diagnostics announce FDA 510(K) clearance of InSure® ONE™

October 19
Clinical Genomics Working with Leading Cancer Center to Evaluate Colvera™ in Patients with Colorectal Cancer

August 31
“Liquid biopsy” colorectal cancer blood test celebrates Eureka moment

August 24
Clinical Genomics hits a milestone in colon cancer prevention

August 21
QIAGEN and Clinical Genomics partner on liquid biopsies to monitor patients for recurrence of colorectal cancer

August 03
New “liquid biopsy” blood test for colorectal cancer set for Eureka moment

June 09
Data Presented at ASCO Annual 2017 Shows Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer

May 31
Clinical Genomics to Present Data at ASCO Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer

March 08
Clinical Genomics Announces Participation in Fortified Provider Network and MultiPlan

January 18
Clinical Genomics to Present Data at ASCO GI Supporting Clinical Utility of Colvera™ in Assessing and Monitoring Patients Following Surgical Resection of Colorectal Cancer

Social Icons

Facebook Twitter LinkedIn

Copyright © 2018 Clinical Genomics Technologies Pty Ltd. All Rights Reserved.